Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
DX8NDG
|
||||
| Drug Name |
7-[(1E)-1-[(tert-butoxy)imino]ethyl]-19-methyl-3,13,19,20-tetraazahexacyclo[14.7.0.0^{2,10}.0^{4,9}.0^{11,15}.0^{17,21}]tricosa-1(16),2(10),4,6,8,11(15),17,20-octaen-14-one
|
||||
| Synonyms |
CHEMBL255281
|
||||
| Indication | Discovery agent | Investigative | [1587926] | ||
| Formula |
C26H27N5O2
|
||||
| Canonical SMILES |
C\\C(=N/OC(C)(C)C)\\c1ccc2[nH]c3c4CCc5nn(C)cc5c4c6C(=O)NCc6c3c2c1
|
||||
| InChI |
InChI=1S/C26H27N5O2/c1-13(30-33-26(2,3)4)14-6-8-19-16(10-14)22-17-11-27-25(32)23(17)21-15(24(22)28-19)7-9-20-18(21)12-31(5)29-20/h6,8,10,12,28H,7,9,11H2,1-5H3,(H,27,32)/b30-13+
|
||||
| InChIKey |
KRCUBKFBOPSUJT-VVEOGCPPSA-N
|
||||
| Target and Pathway | |||||
| Target(s) | Vascular endothelial growth factor receptor 2 | Target Info | [1587926] | ||
| Angiopoietin 1 receptor | Target Info | [1587926] | |||
| NetPath Pathway | IL2 Signaling PathwayNetPath_8:Wnt Signaling Pathway | ||||
| PANTHER Pathway | Angiogenesis | ||||
| VEGF signaling pathwayP00005:Angiogenesis | |||||
| Pathway Interaction Database | HIF-2-alpha transcription factor network | ||||
| Beta3 integrin cell surface interactions | |||||
| Signaling events mediated by TCPTP | |||||
| SHP2 signaling | |||||
| S1P1 pathway | |||||
| VEGF and VEGFR signaling network | |||||
| Integrins in angiogenesis | |||||
| Signaling events mediated by VEGFR1 and VEGFR2 | |||||
| Notch-mediated HES/HEY networkangiopoietinreceptor_pathway:Angiopoietin receptor Tie2-mediated signaling | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.